The CFB invests significant effort into proactively identifying promising technology and through a highly target process adding value that will facilitate the generation of new intellectual property, licensing, strategic partnerships, and/or new company formations in New York State. These investments overtime have resulted in an active pipeline of commercially valuable technology at various stages of development. Some of those technology are highlighted below.
Genetic System to Detect Protein-Protein
Interactions
Stanley Fields, Ph.D., inventor
Licensed to more than 45 companies worldwide
Biomaterial Applications of Hyaluronic Acid
Glenn Prestwich, Ph.D., inventor
Technical basis for the formation of Clear Solutions Biotech, Inc.
LIV Therapy
Clinton Rubin, Ph.D., inventor
Technical basis for the formation of Marodyne Medical
3-D Virtual Colonoscopy
Arie Kaufman, Ph.D., Jerome Liang, Ph.D., inventors
Technical basis for the formation of Viatronix, Inc.
Bioabsorbable Membranes
Benjamin Hsiao, Ph.D., Benjamin Chu, Ph.D., inventors
Technical basis for formation of Stony Brook Technology & Applied
Research, Inc.
Scanning Confocal Ultrasonic Diagnostic System
for Bone Quality
Yi-Xian Qin, Ph.D., Clinton Rubin, Ph.D., inventors
Technical basis for the formation of AcousticScan, Inc.
Development of a Technology to Identify Anti-Metastatic
Drugs
Wen-Tien Chen, Ph.D., inventor
Technical basis for the formation of Vitatex, Inc.
A Novel, Cancer Chemotherapeutic Agent
Paul Bingham, Ph.D., inventor
Technical basis for the formation of Cornerstone Pharmaceuticals, Inc.
A Fibrinogen Prepartaion for Wounds
Richard Clark, M.D., inventor
Technical basis for the formation of NeoMatrix Formulations, Inc.
